Stay updated on Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for a Phase 4 study of deucravacitinib versus placebo in moderate-to-severe scalp psoriasis is displayed, including its eligibility criteria, study locations, outcome measures, and record documents.
    Difference
    61%
    Check dated 2026-11-10T15:10:24.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-11-03T16:14:39.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A sitewide notice about NIH’s terminology transition appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The clinical study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T16:34:04.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T16:32:03.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study record content; a standard error screen and a Home link are shown instead of study details and navigation.
    Difference
    18%
    Check dated 2026-09-22T22:04:46.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now shows a newer revision (v3.7.0) replacing the previous v3.6.6, indicating an update to the study's documentation on the page. This change signals administrative updates rather than new or altered participant information.
    Difference
    0.0%
    Check dated 2026-09-15T20:29:27.000Z thumbnail image

Stay in the know with updates to Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Deucravacitinib in Scalp Psoriasis Clinical Trial page.